Green Square Capital LLC maintained its stake in shares of HCP Inc. (NYSE:HCP) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,800 shares of the real estate investment trust’s stock at the end of the second quarter. Green Square Capital LLC’s holdings in HCP were worth $311,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the stock. JPMorgan Chase & Co. raised its stake in shares of HCP by 4.0% in the first quarter. JPMorgan Chase & Co. now owns 22,671,067 shares of the real estate investment trust’s stock valued at $738,623,000 after buying an additional 877,224 shares during the last quarter. BlackRock Institutional Trust Company N.A. raised its stake in shares of HCP by 1.3% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 18,210,535 shares of the real estate investment trust’s stock valued at $593,299,000 after buying an additional 227,354 shares during the last quarter. Daiwa Securities Group Inc. raised its stake in shares of HCP by 8.0% in the second quarter. Daiwa Securities Group Inc. now owns 16,604,480 shares of the real estate investment trust’s stock valued at $587,467,000 after buying an additional 1,223,911 shares during the last quarter. BlackRock Fund Advisors raised its stake in shares of HCP by 3.8% in the first quarter. BlackRock Fund Advisors now owns 15,129,139 shares of the real estate investment trust’s stock valued at $492,907,000 after buying an additional 547,335 shares during the last quarter. Finally, Shinko Asset Management Co. Ltd. raised its stake in shares of HCP by 5.6% in the second quarter. Shinko Asset Management Co. Ltd. now owns 11,971,364 shares of the real estate investment trust’s stock valued at $423,547,000 after buying an additional 630,695 shares during the last quarter. Institutional investors own 90.96% of the company’s stock.

HCP Inc. (NYSE:HCP) traded up 1.99% during mid-day trading on Thursday, reaching $38.91. The company’s stock had a trading volume of 2,910,589 shares. The firm’s market cap is $18.19 billion. The company has a 50-day moving average price of $38.81 and a 200-day moving average price of $35.64. HCP Inc. has a 12-month low of $25.11 and a 12-month high of $40.43.

HCP (NYSE:HCP) last posted its quarterly earnings data on Tuesday, August 9th. The real estate investment trust reported $0.74 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.70 by $0.04. The business had revenue of $662.20 million for the quarter, compared to analysts’ expectations of $631.25 million. HCP had a negative return on equity of 0.67% and a negative net margin of 2.52%. The business’s revenue was up 9.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.79 EPS. On average, equities research analysts expect that HCP Inc. will post $2.83 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, August 23rd. Shareholders of record on Monday, August 8th were given a dividend of $0.575 per share. The ex-dividend date of this dividend was Thursday, August 4th. This represents a $2.30 annualized dividend and a yield of 5.91%. HCP’s payout ratio is -1,533.33%.

HCP has been the topic of several research analyst reports. Argus restated a “hold” rating on shares of HCP in a research report on Wednesday, June 15th. BTIG Research assumed coverage on HCP in a report on Thursday, August 25th. They issued a “neutral” rating on the stock. Goldman Sachs Group Inc. upgraded HCP from a “sell” rating to a “neutral” rating and increased their price target for the stock from $26.00 to $36.00 in a report on Friday, July 8th. Jefferies Group reiterated a “neutral” rating on shares of HCP in a report on Wednesday, July 6th. Finally, BMO Capital Markets reiterated a “sell” rating on shares of HCP in a report on Monday, June 20th. Seven research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $34.24.

In other news, EVP Jonathan M. Bergschneider sold 7,651 shares of the business’s stock in a transaction that occurred on Tuesday, August 23rd. The stock was sold at an average price of $39.78, for a total value of $304,356.78. Following the sale, the executive vice president now directly owns 54,095 shares of the company’s stock, valued at approximately $2,151,899.10. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Kendall K. Young sold 9,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 24th. The stock was sold at an average price of $39.46, for a total value of $355,140.00. Following the completion of the sale, the insider now directly owns 36,183 shares in the company, valued at $1,427,781.18. The disclosure for this sale can be found here. Company insiders own 0.22% of the company’s stock.

HCP Company Profile

HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.

5 Day Chart for NYSE:HCP

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP Inc. (NYSE:HCP).

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.